ReActiv8-B Clinical Trial
-
Hospitals
Mainstay Medical’s ReActiv8-B Clinical Trial Passes Mid-point
August 03, 2017 Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange:…
Read More »